MYSTERIOUS: Vygr - What They Never Told You

The pharmaceutical industry looks well-positioned for long-term growth. So, let us analyze pharma stocks Procaps Group (PROC), Voyager Therapeutics (VYGR) and Organon & Co. (OGN) to identify whether they are a Buy or Hold. Read on.

The pharma industry’s ability to remain resilient in times of economic uncertainty offers an appealing investment opportunity. Hence, fundamentally sound pharma stocks Catalyst Pharmaceuticals (CPRX), MorphoSys (MOR), and Voyager Therapeutics (VYGR), which seem relatively undervalued to their peers, might be ideal additions to one’s watchlist. Read on.

The medical industry is envisioned to remain afloat and thrive in the foreseeable future, thanks to advanced medical discoveries. Therefore, quality medical stocks Amphastar Pharmaceuticals (AMPH), Ironwood Pharmaceuticals (IRWD), and Voyager Therapeutics (VYGR) could be wise portfolio additions now. Read on….

Voyager Therapeutics Inc (NASDAQ:VYGR) will present new preclinical data on a family of AAV9-derived TRACER capsids demonstrating cross-species central nervous system transduction at the American Society of Gene and Cell Therapy Annual Meeting. Voyager's TRACER capsid discovery platform has identified a novel AAV9-derived capsid, VCAP-102, which demonstrated 50-fold better transduction in mice and…